• Updated

China says it firmly opposes the U.S. adding several prominent Chinese businesses to its list of military-linked companies. The Pentagon on Monday included companies like BYD, Alibaba and Baidu to the list of firms that it deems to have ties with the Chinese military, preventing them from landing U.S. defense contracts. A Chinese Ministry of Commerce spokesperson said the move ignores the consensus reached during U.S. President Donald Trump's summit with Chinese leader Xi Jinping in Beijing last month. Alibaba, BYD and Baidu had previously stated there's no basis for their inclusion on the list.

New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned. But it's a very different kind of treatment than the chemotherapy that is a mainstay for these patients. Called daraxonrasib, the drug is designed to block a mutated protein that fuels most cases of pancreatic cancer, one of the deadliest types of cancer. The research was published Sunday in the New England Journal of Medicine and presented at an American Society of Oncology meeting. Maker Revolution Medicines will seek Food and Drug Administration approval.

  • Updated

Pope Leo XIV has called for robust regulation of artificial intelligence and for its developers to work for the common good rather than profit. He made the call in a sweeping manifesto on safeguarding humankind as the technology impacts everything from work to war. Leo’s first encyclical is called “Magnifica Humanitas” (Magnificent Humanity). Its release Monday has been eagerly awaited ever since history’s first U.S.-born pope announced days after his election that he considered AI to be the biggest challenge facing humanity today.

  • Updated

The four-woman panel at this quarter’s “Women in Business” event featured three business owners and a local hospital executive, offering insights on achieving a successful career. Panelists included Bev Beery, Lynn Carpenter, Tracie Sanchez, and Krista Schrader, each sharing their journey of making a mark in a traditionally male-dominated world.